All In MedTech

Device Trial Radar · NCT07204678

PMCF Study of Precise Pro Rx for Carotid Artery Disease

Post Market Clinical Follow-up Study of the Precise Pro Rx Nitinol Stent System in the Treatment of Carotid Artery Disease (REAL-PRECISE)

Last checked: Nov 20, 2026Latest source record: Mar 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

199

Actual

Start

Oct 30, 2025

Primary completion

Feb 27, 2026

Study completion Feb 27, 2026

Sponsor

Lead sponsor
Cordis US Corp.Not on our public-company list
Sponsor type
Industry
Collaborators
Rede Optimus Hospitalar SA
First posted
Oct 2, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate long-term clinical safety and performance of the PRECISE PRO RX Nitinol Stent System to treat stenotic lesions of the carotid arteries.

Conditions

  • Carotid Artery Stenosis

Interventions

  • PRECISE PRO Rx Nitinol Stent SystemDevice

    The Cordis PRECISE PRO Rx Nitinol Stent System is a single-use device consisting of an endovascular stent and sheath delivery system, intended to deliver a self-expanding endovascular stent to the carotid artery(ies). The stent component imparts an outward radial force on the luminal surface of the vessel wall restoring vascular patency. The Cordis PRECISE PRO Rx Nitinol Stent System is indicated for use in patients with stenotic lesions of the carotid artery(ies).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance Endpoint - Technical SuccessTime frame: At the conclusion of the index procedure

6 more outcomes with a free account

Locations

4 sites in 3 countries. Site status is shown where the registry gives one.

  • University Hospital Tulln

    Tulln, Austria

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.